Skip to main content

JDRF has now rebranded to Breakthrough T1D.
Our name has changed, our mission has not.

JDRF and DigiBete partner up to support young people living with type 1 diabetes

We’re delighted to announce that we’re going to be working together with DigiBete to provide children, young people and their families with the information and support they need to live life well with type 1 diabetes.
Breakthrough T1D profile picture
Kate Gerrard 22 July 2022

We’re delighted to announce that we’re going to be working together with DigiBete to provide children, young people and their families with the information and support they need to live life well with type 1 diabetes.

What will the partnership do?

The partnership will enable both organisations to pool resources and co-create information about a broad range of subjects from daily management to nutrition and wellbeing. The content will be developed with the help of influencers, youth ambassadors and young people with type 1.

The number of children and young people being diagnosed with type 1 diabetes is increasing each year. There has never been a greater need to provide young people and their families with support and information about type 1 diabetes.

Research and advocacy

Working together to amplify our engagement with young people and their families, the partnership will also encourage more young people to become involved in type 1 research and advocacy work, helping them to shape future treatments as well as local and national healthcare services in a way that benefits everyone living with type 1.

Karen Addington, Chief Executive at JDRF said: “I’m thrilled that we’re going to be working more closely with DigiBete in the future. This collaboration will help us to engage with more children, young people and their families, giving them a strong foundation to manage their type 1 into adulthood, where we will continue to support them.”

Help and support

Dr Fiona Campbell, Clinical Lead at DigiBete said: “We are extremely proud to be collaborating with JDRF to provide even more support to families throughout their journey with diabetes. This collaboration will strengthen the support available to all and will make such a difference to the community living with type 1 and their carers. It will enable us to work jointly on some of the big challenges our community faces.”

Ellie, Champion at DigiBete said: “DigiBete helped me to come to terms with my diagnosis of type 1 by helping me see I wasn’t alone in the challenges I faced. It also helped my family and carers who could access resources to understand what I dealt with day to day and how they could help support me with this. By collaborating with JDRF – a charity first introduced to me right after my diagnosis – DigiBete will be able to spread more information backed by the research of JDRF and together they will be able to reach more young people with diabetes, who would benefit from the work undertaken by both JDRF and DigiBete.”

Related news

Read more
Dr Victoria Salem
Research funding
27 March 2023

Type 1 Diabetes Grand Challenge invests £5 million to kick off the race towards a cure

We’re excited to reveal the first research projects funded by the Type 1 Diabetes Grand Challenge, our partnership with the Steve Morgan Foundation and Diabetes UK.

Read more
Daphne Jackson Fellowship logo
Research partnerships
13 March 2023

JDRF sponsors Daphne Jackson Fellowship

We are delighted to announce our latest partnership funding opportunity, offered through the Daphne Jackson Trust.

Read more
Myaware logo - Fighting Myasthenia Together
Research partnerships
18 January 2023

Partnership funding autoimmune research now has over 10 members

Myaware, the only charity in the UK focusing on people affected by myasthenia, is the latest organisation to join Connect Immune Research.

Read more
Partnerships
28 November 2022

Connect Immune Research partnership welcomes the Royal Free Charity

The Royal Free Charity, which supports the three hospitals in the Royal Free London NHS Foundation Trust, is the newest member of the Connect Immune Research initiative.